Trials / Not Yet Recruiting
Not Yet RecruitingNCT07277933
Efficacy and Safety of KHN702 Tablets in Moderate to Severe Post-operative Pain Subjects
Efficacy and Safety of KHN702 Tablets in Moderate to Severe Post-operative Pain Patients: A Randomized, Double-blind, Placebo-Controlled, Phase Ib Trial
- Status
- Not Yet Recruiting
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 24 (estimated)
- Sponsor
- Chengdu Kanghong Pharmaceutical Group Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study is a randomized, double-blind, placebo-controlled, parallel-group clinical trial. To preliminarily evaluate the safety and efficacy of KHN702 tablets in moderate to severe post-operative pain patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | KHN702 | KHN702 tablet for oral administration |
| DRUG | KHN702 placebo | KHN702 placebo tablet for oral administration |
Timeline
- Start date
- 2025-12-01
- Primary completion
- 2026-02-01
- Completion
- 2026-02-01
- First posted
- 2025-12-11
- Last updated
- 2025-12-11
Source: ClinicalTrials.gov record NCT07277933. Inclusion in this directory is not an endorsement.